Pharmacovigilance analysis of infliximab in inflammatory bowel disease: novel safety signals and sex-specific adverse event profiles from the FAERS database (2004-2024).
Saved in:
| Title: | Pharmacovigilance analysis of infliximab in inflammatory bowel disease: novel safety signals and sex-specific adverse event profiles from the FAERS database (2004-2024). |
|---|---|
| Authors: | Liu W; Department of Minimally Invasive Common Surgery, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China., Wang S; Department of Interventional Radiology, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou, Jiangsu, China., Wang G; Department of Minimally Invasive Common Surgery, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China., Qiao Z; Department of Gastroenterology, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China., Rao L; Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, Hubei, China., Cheng L; Department of Interventional Radiology, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou, Jiangsu, China., Shen G; Department of Minimally Invasive Common Surgery, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Mar 24; Vol. 17, pp. 1662405. Date of Electronic Publication: 2026 Mar 24 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41953029 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmacovigilance analysis of infliximab in inflammatory bowel disease: novel safety signals and sex-specific adverse event profiles from the FAERS database (2004-2024). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; Department of Minimally Invasive Common Surgery, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Department of Interventional Radiology, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Wang+G%22">Wang G</searchLink>; Department of Minimally Invasive Common Surgery, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Qiao+Z%22">Qiao Z</searchLink>; Department of Gastroenterology, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Rao+L%22">Rao L</searchLink>; Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.<br /><searchLink fieldCode="AU" term="%22Cheng+L%22">Cheng L</searchLink>; Department of Interventional Radiology, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Shen+G%22">Shen G</searchLink>; Department of Minimally Invasive Common Surgery, Suzhou Ninth People's Hospital, Xuzhou Medical University Suzhou Bay Clinical College, Suzhou, Jiangsu, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Mar 24; Vol. 17, pp. 1662405. <i>Date of Electronic Publication: </i>2026 Mar 24 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41953029 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2026.1662405 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1662405 Titles: – TitleFull: Pharmacovigilance analysis of infliximab in inflammatory bowel disease: novel safety signals and sex-specific adverse event profiles from the FAERS database (2004-2024). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu W – PersonEntity: Name: NameFull: Wang S – PersonEntity: Name: NameFull: Wang G – PersonEntity: Name: NameFull: Qiao Z – PersonEntity: Name: NameFull: Rao L – PersonEntity: Name: NameFull: Cheng L – PersonEntity: Name: NameFull: Shen G IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 03 Text: 2026 Mar 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
